“Gilead's Anido Cell. It's their version of, an anti BCMA CAR T is expected to get approval in December.”
→ Read the source episode
FDA approves Gilead's Anido Cell for at least one indication
John predicts Coursera will run two studies (biomarker and outcomes-based) for their PCSK9/angiotensinogen siRNA program
Greg Savonovich predicts the biotech sector will continue to rally through the rest of 2026
Matt Klein's company will launch brepacitinib within the next two to two and a half months
John predicts France will win the third-place match and Argentina will beat France 3-2 in the World Cup final on Sunday
Yaron Werber predicts Forte's phase 2b celiac disease study will be positive
Yaron Werber expects Forte will report phase 2b celiac and phase 1b alopecia areata data by end of 2026
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.